<DOC>
	<DOCNO>NCT01397214</DOCNO>
	<brief_summary>Phase I study Megace F conduct investigate pharmacokinetics safety compare Megace OS . Phase I study divide 3 part write belows . Part 1 Megace F fast volunteer vs Megace F feed volunteer Part 2 Megace F v Megace OS feed volunteer Part 3 Megace F v Megace OS fast volunteer</brief_summary>
	<brief_title>Pharmacokinetics Megace F Megace OS Under Fasting Fed Conditions Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<criteria>age : 2055 year body weight : great 50kg write informed consent know allergy Megesterol acute chronic disease could affect drug absorption metabolism positive drug alcohol screen smoker 10 cigarette per day 3 month ago participation clinical trial last 3 month prior start study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>